Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer

LESSONS LEARNED: The biweekly GEM plus CBDCA dose and schedule showed satisfactory efficacy with mild toxicities in elderly patients with advanced NSCLC. The biweekly GEM plus CBDCA regimen could be considered an alternative to the 3‐week regimen in NSCLC. BACKGROUND: The gemcitabine (GEM)‐carboplat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: Takayama, Koichi, Ichiki, Masao, Matsumoto, Takemasa, Ebi, Noriyuki, Akamine, Shinji, Tokunaga, Shoji, Yamada, Tadaaki, Uchino, Junji, Nakanishi, Yoichi
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley & Sons, Inc. 2019
Onderwerpen:
Clinical Trial Results
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7066693/
https://ncbi.nlm.nih.gov/pubmed/32162814
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0717
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items